Solution structure and antibody binding studies of the envelope protein domain III from the New York strain of West Nile virus. - Test2 - elhamkhani - TriplyDB

Solution structure and antibody binding studies of the envelope protein domain III from the New York strain of West Nile virus.

Solution structure and antibody binding studies of the envelope protein domain III from the New York strain of West Nile virus.

http://www.wikidata.org/entity/Q30164021

about

Recent progress in West Nile virus diagnosis and vaccination Structure of yellow fever virus envelope protein domain III Stereophysicochemical variability plots highlight conserved antigenic areas in Flaviviruses Peptide inhibitors of dengue virus and West Nile virus infectivity Inhibition of the Hantavirus Fusion Process by Predicted Domain III and Stem Peptides from Glycoprotein Gc Recovery of West Nile Virus Envelope Protein Domain III Chimeras with Altered Antigenicity and Mouse Virulence Development of a humanized monoclonal antibody with therapeutic potential against West Nile virus West Nile virus in complex with the Fab fragment of a neutralizing monoclonal antibody Pathogenesis of West Nile Virus Infection: a Balance between Virulence, Innate and Adaptive Immunity, and Viral Evasion Crystal Structure of West Nile Virus Envelope Glycoprotein Reveals Viral Surface Epitopes Crystal Structure of the West Nile Virus Envelope Glycoprotein Sensitivity and specificity of monoclonal and polyclonal immunohistochemical staining for West Nile virus in various organs from American crows (Corvus brachyrhynchos)Solution structure of the envelope protein domain III of dengue-4 virus Refolding, crystallization and preliminary X-ray structural studies of the West Nile virus envelope (E) protein domain III Type- and Subcomplex-Specific Neutralizing Antibodies against Domain III of Dengue Virus Type 2 Envelope Protein Recognize Adjacent Epitopes Domain III from class II fusion proteins functions as a dominant-negative inhibitor of virus membrane fusion NMR solution structure and backbone dynamics of domain III of the E protein of tick-borne Langat flavivirus suggests a potential site for molecular recognition NMR assignments of the sylvatic dengue 1 virus envelope protein domain III The Stoichiometry of Antibody-Mediated Neutralization and Enhancement of West Nile Virus Infection Dengue virus neutralization by human immune sera: Role of envelope protein domain III-reactive antibody Progress on the development of therapeutics against West Nile virus Effector Functions of Camelid Heavy-Chain Antibodies in Immunity to West Nile Virus Focus on flaviviruses: current and future drug targets Natural Strain Variation and Antibody Neutralization of Dengue Serotype 3 Viruses The Development of Therapeutic Antibodies That Neutralize Homologous and Heterologous Genotypes of Dengue Virus Type 1 Structural basis of West Nile virus neutralization by a therapeutic antibody Bioinformatics in new generation flavivirus vaccines.Role of BC loop residues in structure, function and antigenicity of the West Nile virus envelope protein receptor-binding domain III A VLP-based vaccine targeting domain III of the West Nile virus E protein protects from lethal infection in mice.Structure and function analysis of therapeutic monoclonal antibodies against dengue virus type 2.Phage display approaches for the isolation of monoclonal antibodies against dengue virus envelope domain III from human and mouse derived libraries.Vaccination of mice using the West Nile virus E-protein in a DNA prime-protein boost strategy stimulates cell-mediated immunity and protects mice against a lethal challenge.An Approach for Zika Virus Inhibition Using Homology Structure of the Envelope Protein.Genome-wide patterns of intrahuman dengue virus diversity reveal associations with viral phylogenetic clade and interhost diversity.Development of effective therapies against West Nile virus infection.Mapping and analysis of West Nile virus-specific monoclonal antibodies: prospects for vaccine development.The molecular basis of antibody-mediated neutralization of West Nile virus.Functional analysis of antibodies against dengue virus type 4 reveals strain-dependent epitope exposure that impacts neutralization and protection.A review of vaccine approaches for West Nile virus.B cell response and mechanisms of antibody protection to West Nile virus.

P2860

Q21284433-EC10C816-8561-407B-8E6A-483A4FB6C8FA Q24289393-87FB8A46-E61A-4B44-A185-DA6FF06333CC Q24804265-6A1CA4C6-88F0-47DE-9475-DD81D11F6410 Q24813811-6C8C75CD-A0B0-4F78-940E-65CBF2D72295 Q26700097-96BF4325-9FE9-4AD9-802B-E0DEA32E1AAB Q27469118-AB5DF607-D5BA-4645-ABEE-9F8C2847CF1C Q27473186-29432B5C-05F1-4957-9BF0-91FD6CE2363F Q27477479-B766F9BF-A5F3-4BB8-8120-41CD467B742A Q27477543-3535FA62-A6A2-47EB-A92A-3ACFF6E7F0C6 Q27477610-5C2CA853-AA2C-4838-8659-AFA40E935274 Q27477648-932087FF-BB98-49AF-BEF0-6F4C5DA4405E Q27480292-57CE09CF-A1B2-487C-B98B-DD624821163B Q27480990-BC20DDBA-167F-466D-AADC-E24D157EE06E Q27481038-A806531E-06D2-40CE-9D44-76DC7AB4556F Q27485031-5BAD7388-ED96-4D8D-AED7-9CF447A0C3A8 Q27485039-07D227C3-52EE-4851-9730-760BF924A0B5 Q27485383-A7C80908-1ED5-4D7B-B603-E3586D0A69D4 Q27487416-A39A84EC-EA4D-4510-89A9-31E98B81276B Q27488224-FCA2DC15-1D13-4094-B302-6B6CF7E352F7 Q27489654-353C3DF2-E761-4CE5-8F42-46321D8E07E0 Q27489893-B014400C-E6AD-4F6E-87D0-7FEDE8D8DB5A Q27490881-1AD83FC4-CE6C-4430-B463-BAC0E76A0780 Q27490926-39EF0181-07F8-4EA5-9756-49EB6B4DDE31 Q27491299-2F7D6AB4-295F-4091-BEC4-4ADCA938D901 Q27491317-12CEDAE5-97E4-4466-BD4A-745CAE62C7E5 Q29618168-733AD92E-42DC-40EF-9605-8F9D51371F0C Q33839001-9A983300-225F-4C97-B60F-FF939778A97B Q33962622-B5B4F1A7-AB49-45BA-8F5D-B3CDB6AB8AB3 Q34039347-EB0F9B71-0DDB-4BC7-9068-5F16AE174A34 Q34120070-D4A0123A-76E1-48A4-844E-BE73A958D789 Q34226542-D5C8F768-BCF5-4ECF-85F3-C3C5FD01EAD1 Q35087579-48D018E6-4D3B-4A6C-A10D-978FABD3BD60 Q36147591-1A7DF05C-0369-40CF-9C74-6423077A40F7 Q36172100-9402D560-9793-4944-BF5C-F5FC360610E5 Q36322125-593AEAD2-FAF8-488B-A0BE-1466FC5B7426 Q36780133-BD7F5497-1B2D-4010-9A33-0EEEFA86B429 Q36842733-622419F7-A5D7-48B7-955F-40CFC37EA5DB Q37123259-D009A66B-73B6-4FAF-B7FC-AE1938EB3845 Q37236968-5EF2F388-C7BA-4940-A609-EF2998081188 Q37673123-C475D756-F70E-4FC6-B627-0C96971E70D6

P2860

Solution structure and antibody binding studies of the envelope protein domain III from the New York strain of West Nile virus.

http://www.wikidata.org/entity/Q30164021

description

2004 nî lūn-bûn

@nan

2004 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2004 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

name

Solution structure and antibod ...... ork strain of West Nile virus.

@ast

Solution structure and antibod ...... ork strain of West Nile virus.

@en

type

label

Solution structure and antibod ...... ork strain of West Nile virus.

@ast

Solution structure and antibod ...... ork strain of West Nile virus.

@en

prefLabel

Solution structure and antibod ...... ork strain of West Nile virus.

@ast

Solution structure and antibod ...... ork strain of West Nile virus.

@en

P1433

Q30164021-CC4553B3-B7FD-4FBE-A24F-6C4AD8DB6F79

P1476

Q30164021-A66AB911-45CD-4910-A1BF-2DD256385BFA

P2093

Q30164021-45861CBD-0AC2-4FF7-A908-074CD9769B1B

Q30164021-63D0FC46-5267-4DDF-8967-34DFCB074951

Q30164021-786E6C42-F7E3-42E9-88B2-B85600DD9559

Q30164021-9A119E95-DEFF-468D-8599-C8F111854139

P2860

Q30164021-1C327FCB-5816-408B-898D-22BFD60CF193

Q30164021-2010E4C2-5D68-4C74-9C21-5A56919F9F72

Q30164021-30C7F1A1-172C-4FE6-80EC-01C79385B1B7

Q30164021-3A20720C-1922-4C4F-A53D-9EBCDE543517

Q30164021-4155BA53-3A76-4C7A-859C-BD6CE833708A

Q30164021-48A1D5B0-12B4-4CCD-A9B3-256C0A8E1B49

Q30164021-4BC344A3-FC7B-413C-BFE1-E32F97F87196

Q30164021-5BEFA97B-2CAF-4784-8FD2-AAA213FE1AFC

Q30164021-60F2E745-BEC4-4AD3-AFF9-CEA9E87BE444

Q30164021-61BC8877-69A5-482F-9943-DDC91EBF77EF

P304

Q30164021-E998756D-72A0-48F7-B331-D4AF136512C9

P31

Q30164021-FAC96663-0264-462B-B512-B10F608B9660

P356

Q30164021-425B0D4B-0DB5-45C8-81D0-7EC3604115AC

P407

Q30164021-92E48496-C31C-442E-8D1D-40301C0923DC

P433

Q30164021-7968CC8C-5648-4E4E-BB8A-BAED4340C970

P478

Q30164021-F62E665E-D026-4F18-8CE1-BA7EC3BD266D

P50

Q30164021-BD1D029D-C28F-4712-9CE1-C5AE9F551A57

Q30164021-CE13D96B-740A-4B5D-BAC8-8AE97C17CEA6

P577

Q30164021-376F968C-B44D-442D-885D-96E331210E85

P698

Q30164021-7392909A-7A5A-404E-82A9-D88175C97F0D

P921

Q30164021-66D18463-064F-45DE-AE6F-509E8913E33E

Q30164021-F6DD32D6-2D17-4BED-A57F-4180F15077D6

P356

P1433

Journal of Biological Chemistry

P1476

Solution structure and antibod ...... ork strain of West Nile virus.

@en

P2093

David E Volk

http://www.w3.org/2001/XMLSchema#string

David G Gorenstein

http://www.w3.org/2001/XMLSchema#string

Deborah A Kallick

http://www.w3.org/2001/XMLSchema#string

Michael R Holbrook

http://www.w3.org/2001/XMLSchema#string

P2860

Structure of dengue virus: implications for flavivirus organization, maturation, and fusion

Identification of neutralizing epitopes within structural domain III of the West Nile virus envelope protein.

A functional epitope determinant on domain III of the Japanese encephalitis virus envelope protein interacted with neutralizing-antibody combining sites.

A ligand-binding pocket in the dengue virus envelope glycoprotein

Structural basis of a flavivirus recognized by its neutralizing antibody: solution structure of the domain III of the Japanese encephalitis virus envelope protein

Structure of the dengue virus envelope protein after membrane fusion

The envelope glycoprotein from tick-borne encephalitis virus at 2 A resolution

MOLMOL: a program for display and analysis of macromolecular structures

Protein backbone angle restraints from searching a database for chemical shift and sequence homology

NMR structure of the Apo-S100P protein

P304

38755-38761

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1074/JBC.M402385200

http://www.w3.org/2001/XMLSchema#string

P407

P433

37

http://www.w3.org/2001/XMLSchema#string

P478

279

http://www.w3.org/2001/XMLSchema#string

P50

Alan D T Barrett

David W C Beasley

P577

2004-06-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15190071

http://www.w3.org/2001/XMLSchema#string

P921

West Nile virus